AMA Cuts Devices From Vote Restricting Sales Reps; HIPAA Made Relevant
This article was originally published in The Gray Sheet
The American Medical Association's decision to bar drug sales reps from doctors' offices and surgical suites stems from concerns about device manufacturer salespeople, but does not apply to device reps
You may also be interested in...
A settlement between Guidant and the Department of Justice over deficient medical device reporting of deaths and serious injuries, combined with public awareness of the lapses, sets the stage for closer scrutiny of MDR practices across the industry
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.